CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphomaHongwen Li, Mingzhi Zhang, Zhaoming Li et al.|BMC Medicine|2023Cited by 20
LMP1 enhances aerobic glycolysis in natural killer/T cell lymphomaWenting Song, Mingzhi Zhang, Yuyang Gao et al.|Cell Death and Disease|2024Cited by 10
A second‐generation <scp>CD38‐CAR‐T</scp> cell for the treatment of multiple myelomaHongwen Li, Mingzhi Zhang, Jing Li et al.|Cancer Medicine|2023Cited by 7
Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphomaGong Chen, Mingzhi Zhang, Zhuangzhuang Shi et al.|Annals of Hematology|2023Cited by 3